2022 - Research.com Best Scientist Award
2019 - Distinguished Scientist Award, American Heart Association
Deepak L. Bhatt focuses on Internal medicine, Cardiology, Myocardial infarction, Surgery and Clopidogrel. Internal medicine is represented through his Percutaneous coronary intervention, Stroke, Hazard ratio, Randomized controlled trial and Coronary artery disease research. His Cardiology research is multidisciplinary, relying on both Diabetes mellitus and Stent.
As part of his studies on Myocardial infarction, Deepak L. Bhatt often connects relevant areas like Platelet aggregation inhibitor. Deepak L. Bhatt has included themes like Gastroenterology and Placebo in his Surgery study. In his study, which falls under the umbrella issue of Clopidogrel, P2Y12 is strongly linked to Anesthesia.
Deepak L. Bhatt mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery. In the subject of general Internal medicine, his work in Stroke, Coronary artery disease, Clopidogrel and Aspirin is often linked to In patient, thereby combining diverse domains of study. His Stroke study combines topics in areas such as Physical therapy, Atrial fibrillation and Emergency medicine.
His studies in Cardiology integrate themes in fields like Diabetes mellitus and Randomized controlled trial. His work carried out in the field of Myocardial infarction brings together such families of science as Odds ratio, Intensive care medicine and Hazard ratio. His Percutaneous coronary intervention research includes themes of Conventional PCI, Antithrombotic and Angioplasty.
His scientific interests lie mostly in Internal medicine, Cardiology, In patient, Myocardial infarction and Randomized controlled trial. Deepak L. Bhatt works mostly in the field of Internal medicine, limiting it down to topics relating to Diabetes mellitus and, in certain cases, Hazard ratio, as a part of the same area of interest. In most of his Cardiology studies, his work intersects topics such as Blood pressure.
His research in Myocardial infarction intersects with topics in Aspirin, Interquartile range, Cohort study and Rivaroxaban. His study looks at the relationship between Aspirin and topics such as Disease, which overlap with Renal function. Deepak L. Bhatt combines subjects such as Artery, Clinical trial, Statin, Relative risk and Adverse effect with his study of Randomized controlled trial.
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Clinical trial and In patient. His study explores the link between Internal medicine and topics such as Diabetes mellitus that cross with problems in Kidney disease. His studies deal with areas such as Eicosapentaenoic acid and Blood pressure as well as Cardiology.
His biological study spans a wide range of topics, including Coronary artery disease, Interquartile range, Cohort study and Stroke. His Clinical trial research integrates issues from Cross-sectional study, Cohort, MEDLINE and Atherosclerotic cardiovascular disease. His work focuses on many connections between Percutaneous coronary intervention and other disciplines, such as Atrial fibrillation, that overlap with his field of interest in Platelet aggregation inhibitor, Surgery, Venous thromboembolism, Intensive care medicine and Anticoagulant.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Harold P. Adams;Gregory Del Zoppo;Mark J. Alberts;Deepak L. Bhatt.
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica;Deepak L. Bhatt;Deepak L. Bhatt;Eugene Braunwald;P. Gabriel Steg.
The New England Journal of Medicine (2013)
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger.
The New England Journal of Medicine (2006)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran;Sunil V. Rao;Deepak L. Bhatt;C. Michael Gibson.
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand.
The New England Journal of Medicine (2012)
A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt;David E. Kandzari;John M. Flack;Barry T. Katzen.
The New England Journal of Medicine (2014)
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im.
The Lancet (2019)
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis
Deepak L. Bhatt;P. Gabriel Steg;E. Magnus Ohman;Alan T. Hirsch.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt;P. Gabriel Steg;Michael Miller;Eliot A. Brinton.
The New England Journal of Medicine (2019)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet;Holger Thiele;Emanuele Barbato;Olivier Barthélémy.
European Heart Journal (2021)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: